FOR IMMEDIATE RELEASE SCIENTIFIC LEADERS IN NEUROLOGICAL INFECTIONS ADDRESS SHORT AND LONG TERM COVID-19 IMPLICATIONS AT ASENT 2021 ANNUAL MEETING Speakers from NINDS, Yale and University of Gothenburg discuss research in acute and chronic neurological implications of COVID-19 February 3, … Read More
Designed for new investigators, the Clinical Trials training course will cover basic clinical research in drug development. The course was conceptualized by members of the ASENT Board of Directors, who identified the need for more formalized training on the clinical … Read More
The 2021 session of the Training in Neurotherapeutics Discovery and Development for Academic Scientists Course will be held February 8-12, 2021. Due to the ongoing global pandemic, the course will be held virtually instead of in-person. The course runs in … Read More
ASENT is pleased to welcome our newest cohort of ASENT Board Members. Below you will find bios and headshots to share some of the outstanding work this group of individuals continues to do in the field of Neurotherapeutics. Sharon … Read More
The American Society for Experimental Neurotherapeutics (ASENT) is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders. Its primary goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.
ASENT engages in scientific exchanges to encourage contacts between those involved in the discovery and development of neurotherapeutics and to provide opportunities for dialogue between the interested groups. The society organizes education and training and publishes a journal for healthcare practitioners, scientists and officials participating in the neurotherapeutics field, which serves as a forum for its members and interested groups addressing diverse issues.
Vision, Mission, Goals and Team
To advance the science of neurotherapeutics and to improve and accelerate the development of new treatments
ASENT combines academia, government, clinical community, industry and advocacy to enable and advance the discovery, translation and development of neurotherapeutics.
Drive the development of next generation therapeutics through world-class dialogue. Promote the highest scientific and ethical principles in therapeutic discovery and clinical investigation. Create a strong organization scaffold to support ASENT.
Thank You to Our Sponsors
“The ASENT Annual Meeting features great topics and interactions. It is unlike any other meeting.”
~ Member, Chair of Neurology
ASENT Career Center
Recent Publications on COVID-19
Join ASENT Today
ASENT members include leaders in academia, government, advocacy and industry engaged in discovery and development of neurotherapeutics.
Each year the ASENT Annual Meeting features sessions on emerging therapies in a wide variety of neurologic disease states from Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and a variety of other Neurodegenerative Disorders. Technological breakthroughs featured include the use of DBS, spinal cord stimulation, genomic-based drug discovery, new drug delivery systems.
Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities.The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field.
IF: 6.035 (2019) | 5YR IF: 6.453 (2019) | Submission to first decision: 24 days | Submission to acceptance: 104 days | Downloads: 508,580 (2019)